When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 29, 2024.

Where is the headquarters located?

The headquarters is located at: ul. Jana Kilińskiego 78, 22-400 Zamość.

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of USD 4,020,861, representing an increase of 29.5% compared to 2024.

Yes, the company recorded a net profit of USD 725,263 in 2025, meaning the company decreased its profit by 29.6%.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to USD 934,177 in 2025, representing 34% of all operating expenses.

Zakład Patomorfologii Alfamedsp. z o.o.

KRS: NIP: REGON:

Overview

Status

Deleted

Activity period

2024-03-29 – 2026-10-06

Activity description

Zakład Patomorfologii Alfamed is a pathology laboratory that offers diagnostic services including liquid cytology using BD SurePath™ and HPV DNA testing with BD Onclarity™. The company provides tools for diagnostic results and collaborates with various partners in the healthcare sector.

Registered address

ul. Jana Kilińskiego 78, 22-400 Zamość, Poland

Phone

Electronic delivery address

AE:PL-79079-84741-DRVIF-19

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs voivodeship

Revenue

This companyUSD 4.02mMedianUSD 167.33kAverageUSD 3.96m

Net profit

This companyUSD 725.26kMedianUSD 3.70kAverageUSD 86.22k

Operating costs

This companyUSD 2.78mMedianUSD 150.06kAverageUSD 3.71m

Assets

This companyUSD 1.25mMedianUSD 137.92kAverageUSD 4.69m

Bank accounts

Registered as a VAT taxpayer on 2024-10-31. Active

mBank
05 1140 0039 0000 7067 5500 1002
mBank
32 1140 0039 0000 7067 5500 1001
mBank
75 1140 0039 0000 7067 5500 1003

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

15 public aid cases recorded, with a total value of $136,463.

Grant date	Purpose	Gross amount	Granting body
Oct 19, 2022	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	––	Prezes Banku Gospodarstwa Krajowego
Oct 19, 2021	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	––	Prezes Banku Gospodarstwa Krajowego
Oct 19, 2020	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	––	Prezes Banku Gospodarstwa Krajowego

Tenders

No recorded participation in tenders.

National Health Fund (NFZ) contracts

Zakład Patomorfologii Alfamed has been an NFZ healthcare provider since 2008. In 2026 it is performing 1 contract worth USD 318.33k. All its contracts were worth USD 2.31m in total.

NFZ contract value by year (in k USD)

Type of care	NFZ branch	Contracts	Value in 2026
Profilaktyczne programy zdrowotne	lubelskie	1	USD 318.33k

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Beneficial owners

Person	Rights

Change history

Date	Event
2026-10-06	PKD change (Added: 86.90.E)
2026-10-06	Struck off the register
2024-03-29	Entered in the register

FAQ

Last updated: 2026-10-06